ARCS
ARCS Inc. is a Tokyo-based AI and robotics startup developing automation and standardization tools for research laboratories, anchored by a deep-learning computer vision system for non-invasive bovine sperm DNA damage analysis, serving fertility clinics, research labs, and the livestock breeding industry.
- Company typePrivate
- Founded2022
- HeadquartersTokyo, Japan
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What ARCS does
ARCS Inc. (株式会社アークス) is a Tokyo-based AI and robotics startup founded in March 2022 that develops automation and standardization tools for research laboratory operations. The company's product thesis is to reduce manual workload and standardize workflows in scientific research environments by combining applied AI with robotic automation, anchored by academic partnerships with Tokyo University of Science and Tokyo Medical and Dental University. Its primary disclosed product is a deep-learning computer vision system that performs non-invasive, real-time image-based analysis of DNA damage in bovine sperm, launched in July 2025 and presented at the Japanese Society of Animal Science 133rd Conference in September 2025 — the company's first concrete commercial reference point in the livestock breeding vertical.
The company targets three end markets in parallel: fertility treatment clinics seeking AI-assisted sperm analysis, university and corporate research laboratories seeking workflow automation, and the livestock industry seeking non-invasive reproductive evaluation. It sells directly to medical institutions and research labs through a direct sales motion with field demonstrations and technical support to physicians and embryologists; pricing is not publicly disclosed. Revenue is not reported, consistent with a pre-commercial scale of 1–10 employees and a flagship product that only recently entered the market.
ARCS is venture-backed, having raised approximately ¥940 million (~$6.2M USD) in equity across a 2022 pre-seed, a 2023 pre-seed, and a 2025 pre-Series A round (totaling ¥800M across a January first close led by JAFCO and a May close), plus non-dilutive support from NEDO Deep Tech Seeds STS and the Ministry of Health, Labour and Welfare SBIR Phase 3 program. The founding team — CEO Masayasu Tanase (ex-Toyota advanced safety R&D) and CTO Yuya Maruyama (ex-Seiko Epson medical device AI; joined 2023) — provides a hybrid of automotive-grade engineering, medical-device development, and applied AI expertise, with no public listing, parent company, or acquisition history.
ARCS firmographics
Firmographics- Name
- ARCS
- Legal name
- 株式会社アークス
- Website
- https://arcs-inc.jp
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- ARCS Inc. is a Tokyo-based AI and robotics startup developing automation and standardization tools for research laboratories, anchored by a deep-learning computer vision system for non-invasive bovine sperm DNA damage analysis, serving fertility clinics, research labs, and the livestock breeding industry.
- Ownership category
- akta.pro rank
ARCS industry classification
Industry- Product category
- Medical AI Software / Lab Automation
- NAICS
- Support Activities for Animal Production (11521), Cattle Ranching and Farming (1121)
- SIC
- Agricultural Prod-Livestock & Animal Specialties (200), Agricultural Services (700)
- akta.pro primary industry
- Breeding Program Design & Genetic Consulting (Mating Plans, EPD/Index Selection) (AFACAEAD)
Keywords
Where ARCS is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
ARCS business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Distribution channels1 record
Marketing channels3 records
ARCS product offering
Product offeringCore offering
ARCS Inc. develops AI and robotics-based automation tools that standardize and improve efficiency in research laboratory operations. Its primary commercial offering is a deep learning-based computer vision system that non-invasively and in real-time analyzes DNA damage in bovine sperm from image data, supporting fertility treatment clinics, university/corporate research labs, and the livestock breeding industry.
Product overview
ARCS Inc. is a single-product AI/robotics company that develops automation tools combining AI and robotics technologies to support efficiency and standardization of operations in research laboratories. The company focuses on image-based AI analysis systems for scientific research applications. Its primary product is a deep learning-based computer vision system for non-invasive analysis of DNA damage in bovine sperm, developed for the livestock breeding industry.
Differentiator
Problem solved
Functional benefit
Products and services
- Deep Learning-based Bovine Sperm DNA Damage Analysis AI System An AI system utilizing deep learning technology to non-invasively and in real-time analyze DNA damage in bovine sperm from image data. The system enables rapid and accurate evaluation of sperm quality, contributing to improved reproductive efficiency in livestock production. Targeted at livestock industry buyers, fertility clinics, and research laboratories.
- Research Lab Automation Tools (AI and Robotics Solutions) Automation tools leveraging AI and robotics technologies developed by ARCS to support efficiency and standardization of operations in research laboratories. The company focuses on image-based AI analysis systems for scientific research applications, targeting operational efficiency, labor reduction, and standardization for university and corporate research labs.
- Assisted Reproductive Medical Devices Medical devices utilizing robotics and AI technology for assisted reproductive applications, targeted at fertility treatment clinics and medical institutions. ARCS is developing these devices in collaboration with Tokyo Medical and Dental University to improve reproductive efficiency and standardize analysis processes in clinical settings.
Quantifiable outcome
- Real-time non-invasive analysis of bovine sperm DNA damage, enabling faster evaluation compared to traditional invasive methods
Companies that use ARCS
Customer profileSegments3 records
Ideal customer profiles3 records
ARCS technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature1 record
ARCS partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Tokyo Medical and Dental University (東京医科歯科大学)coreEstablished joint research contract and obtained university-certified venture status through collaboration with Tokyo Medical and Dental University. This partnership involves joint research development and provides university backing for the company's medical technology.
- Japan Zeon Co., Ltd. (日本ゼオン株式会社)minorSigned a memorandum of understanding for collaboration with Japan Zeon Co., Ltd., a specialty chemicals company. The nature of the collaboration is not specified beyond the MOU.
- SSG Holdings Co., Ltd. and Sun Sun House Co., Ltd.minorPartnership through ARCS 2.0 phase involving blockchain and real-world assets. ARX tokens are used for property transactions, rentals, and loyalty rewards in the traditional Japanese kominka homes market in Tokyo. This appears to be related to a separate ARX token/blockchain project rather than the core AI/robotics business.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
ARCS competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
ARCS social profiles
Digital presenceARCS financial estimates
Financial estimateRevenue estimate
Valuation estimate
ARCS leadership team
Management profileNumber of profiles
Profiles2 records
ARCS funding detail
Funding detailFunding overview
Funding rounds3 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ARCS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ARCS
What does ARCS do?
ARCS Inc. develops AI and robotics-based automation tools that standardize and improve efficiency in research laboratory operations. Its primary commercial offering is a deep learning-based computer vision system that non-invasively and in real-time analyzes DNA damage in bovine sperm from image data, supporting fertility treatment clinics, university/corporate research labs, and the livestock breeding industry.
Is ARCS a public or private company?
ARCS is a private company. It is classified as venture growth investor backed and is currently operating.
When was ARCS founded?
ARCS was founded in 2022. It employs 1 to 10 people.
Where is ARCS based?
ARCS is headquartered in Tokyo, Japan, in the Asia region.
Does ARCS have an API?
No public API is recorded for ARCS.
What industry is ARCS in?
ARCS's product category is Medical AI Software / Lab Automation. Its primary akta.pro industry code is AFACAEAD, Breeding Program Design & Genetic Consulting (Mating Plans, EPD/Index Selection). Its NAICS code is 11521 and its SIC code is 200.